Published in Arch Iran Med on January 01, 2013
The gastro-esophageal malignancies in northern Iran (GEMINI) is expected to be the pioneer in the implementation and application of the methodology used in evaluating research impact. Arch Iran Med (2013) 1.07
Authors' reply. Arch Iran Med (2013) 0.75
Burden of Gastrointestinal and Liver Diseases in Middle East and North Africa: Results of Global Burden of Diseases Study from 1990 to 2010. Middle East J Dig Dis (2015) 0.75
Developing the environmental and lifestyle exposure assessment (ELEA) tool for cancer epidemiology research in low resource settings. J Glob Health (2016) 0.75
Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet (1997) 44.03
Tea drinking habits and oesophageal cancer in a high risk area in northern Iran: population based case-control study. BMJ (2009) 5.79
Oesophageal cancer studies in the Caspian Littoral of Iran: the Caspian cancer registry. Br J Cancer (1973) 2.93
Opium, tobacco, and alcohol use in relation to oesophageal squamous cell carcinoma in a high-risk area of Iran. Br J Cancer (2008) 2.79
Five common cancers in Iran. Arch Iran Med (2010) 2.69
The prevalence of hepatitis B surface antigen and anti-hepatitis B core antibody in Iran: a population-based study. Arch Iran Med (2009) 2.67
A pilot double-blind randomised placebo-controlled trial of the effects of fixed-dose combination therapy ('polypill') on cardiovascular risk factors. Int J Clin Pract (2010) 2.57
Cancer occurrence in Ardabil: results of a population-based cancer registry from Iran. Int J Cancer (2003) 2.53
Epidemiologic features of upper gastrointestinal tract cancers in Northeastern Iran. Br J Cancer (2004) 2.46
Seroprevalence of hepatitis C virus: the first population-based study from Iran. Int J Infect Dis (2010) 2.32
Esophageal cancer in the Caspian littoral of Iran: initial studies. Science (1972) 2.31
Opportunities for cancer epidemiology in developing countries. Nat Rev Cancer (2004) 2.25
Gastric cancer in Iran: epidemiology and risk factors. Arch Iran Med (2009) 2.20
Cohort Profile: The Golestan Cohort Study--a prospective study of oesophageal cancer in northern Iran. Int J Epidemiol (2009) 2.10
Validity and reliability of a new food frequency questionnaire compared to 24 h recalls and biochemical measurements: pilot phase of Golestan cohort study of esophageal cancer. Eur J Clin Nutr (2006) 2.03
Oesophageal cancer studies in the Caspian Littoral of Iran: results of a case-control study. Br J Cancer (1979) 1.96
Reliability and validity of opiate use self-report in a population at high risk for esophageal cancer in Golestan, Iran. Cancer Epidemiol Biomarkers Prev (2004) 1.95
Socio-economic status and oesophageal cancer: results from a population-based case-control study in a high-risk area. Int J Epidemiol (2009) 1.77
Obesity and hypertension in an Iranian cohort study; Iranian women experience higher rates of obesity and hypertension than American women. BMC Public Health (2006) 1.75
Polycyclic aromatic hydrocarbon exposure in oesophageal tissue and risk of oesophageal squamous cell carcinoma in north-eastern Iran. Gut (2010) 1.71
Declining incidence of esophageal cancer in the Turkmen Plain, eastern part of the Caspian Littoral of Iran: a retrospective cancer surveillance. Cancer Detect Prev (2006) 1.65
Persistent alanine aminotransferase elevation among the general Iranian population: prevalence and causes. World J Gastroenterol (2008) 1.59
High exposure to polycyclic aromatic hydrocarbons may contribute to high risk of esophageal cancer in northeastern Iran. Anticancer Res (2005) 1.57
Golestan cohort study of oesophageal cancer: feasibility and first results. Br J Cancer (2005) 1.54
Esophageal cancer studies in the Caspian littoral of Iran: results of population studies--a prodrome. Joint Iran-International Agency for Research on Cancer Study Group. J Natl Cancer Inst (1977) 1.53
Incidence and age distribution of colorectal cancer in Iran: results of a population-based cancer registry. Cancer Lett (2005) 1.53
Tooth loss and lack of regular oral hygiene are associated with higher risk of esophageal squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev (2008) 1.47
Verbal autopsy: reliability and validity estimates for causes of death in the Golestan Cohort Study in Iran. PLoS One (2010) 1.47
Ecologic study of serum selenium and upper gastrointestinal cancers in Iran. World J Gastroenterol (2004) 1.47
Seroprevalence and risk factors of hepatitis A virus infection in Iran: a population based study. Arch Iran Med (2010) 1.35
Oesophageal cancer in Golestan Province, a high-incidence area in northern Iran - a review. Eur J Cancer (2009) 1.27
The upper normal limit of serum alanine aminotransferase in Golestan Province, northeast Iran. Arch Iran Med (2008) 1.25
Oesophageal cancer among the Turkomans of northeast Iran. Br J Cancer (2000) 1.22
The role of diet and other environmental factors in the causation of gastric cancer in Iran--a population based study. Int J Cancer (2009) 1.21
Comparison of breast cancer survival in two populations: Ardabil, Iran and British Columbia, Canada. BMC Cancer (2009) 1.20
Cancer registry in Iran: a brief overview. Arch Iran Med (2008) 1.19
Familial risks of esophageal cancer among the Turkmen population of the Caspian littoral of Iran. Int J Cancer (2006) 1.15
Distinct pattern of TP53 mutations in squamous cell carcinoma of the esophagus in Iran. Oncogene (2001) 1.12
Patterns of food and nutrient consumption in northern Iran, a high-risk area for esophageal cancer. Nutr Cancer (2009) 1.07
Oesophageal lesions in northern Iran: a premalignant condition? Lancet (1979) 1.03
Genetic polymorphisms in three Iranian populations with different risks of esophageal cancer, an ecologic comparison. Cancer Lett (2004) 1.00
Pictogram use was validated for estimating individual's body mass index. J Clin Epidemiol (2009) 0.96
Gastric cancer in Ardabil, Iran--a review and update on cancer registry data. Asian Pac J Cancer Prev (2010) 0.93
Endoscopic esophageal cancer survey in the western part of the Caspian Littoral. Dis Esophagus (2002) 0.93
Vitamin deficiency in Golestan Province, northern Iran: a high-risk area for esophageal cancer. Arch Iran Med (2010) 0.92
Renal function and risk factors of moderate to severe chronic kidney disease in Golestan Province, northeast of Iran. PLoS One (2010) 0.90
Epidemiology of upper gastrointestinal cancers in Iran: a sub site analysis of 761 cases. World J Gastroenterol (2007) 0.90
Investigation of NQO1 genetic polymorphism, NQO1 gene expression and PAH-DNA adducts in ESCC. A case-control study from Iran. Genet Mol Res (2010) 0.90
Epidemiologic study of esophageal carcinoma in Iran. Int Surg (1971) 0.88
A new horizon in primary prevention of cardiovascular disease, can we prevent heart attack by "heart polypill"? Arch Iran Med (2008) 0.85
Development of gastroenterology and hepatology in Iran: part I-training programs and the Iranian association of gastroenterology and hepatology. Arch Iran Med (2009) 0.82
A pilot double-blind randomised placebo-controlled trial of the effects of fixed-dose combination therapy ('polypill') on cardiovascular risk factors. Arch Iran Med (2011) 0.81
Prevalence of esophageal cancer risk factors among Turkmen and non-Turkmen ethnic groups in a high incidence area in Iran. Arch Iran Med (2010) 0.79
Development of gastroenterology and hepatology in Iran: Part II- advances in research and therapeutic modalities. Arch Iran Med (2009) 0.79
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 41.47
Genome-wide association study identifies novel breast cancer susceptibility loci. Nature (2007) 29.23
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 26.95
International network of cancer genome projects. Nature (2010) 20.35
A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25. Nature (2008) 16.10
The clonal and mutational evolution spectrum of primary triple-negative breast cancers. Nature (2012) 11.91
Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. Lancet (2012) 11.32
Large-scale genotyping identifies 41 new loci associated with breast cancer risk. Nat Genet (2013) 8.24
A common coding variant in CASP8 is associated with breast cancer risk. Nat Genet (2007) 7.35
Association between body-mass index and risk of death in more than 1 million Asians. N Engl J Med (2011) 6.89
Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics. PLoS Genet (2008) 6.22
Lung cancer susceptibility locus at 5p15.33. Nat Genet (2008) 5.99
Tea drinking habits and oesophageal cancer in a high risk area in northern Iran: population based case-control study. BMJ (2009) 5.79
A genome-wide association study of lung cancer identifies a region of chromosome 5p15 associated with risk for adenocarcinoma. Am J Hum Genet (2009) 5.62
Smoking and mortality--beyond established causes. N Engl J Med (2015) 5.54
Association of coffee drinking with total and cause-specific mortality. N Engl J Med (2012) 5.31
Validity and repeatability of a simple index derived from the short physical activity questionnaire used in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Public Health Nutr (2003) 5.18
Assessment of cumulative evidence on genetic associations: interim guidelines. Int J Epidemiol (2007) 4.96
Prospective study of risk factors for esophageal and gastric cancers in the Linxian general population trial cohort in China. Int J Cancer (2005) 4.69
Alcohol drinking in never users of tobacco, cigarette smoking in never drinkers, and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. J Natl Cancer Inst (2007) 4.55
Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies. J Natl Cancer Inst (2010) 4.54
Meat, fish, and colorectal cancer risk: the European Prospective Investigation into cancer and nutrition. J Natl Cancer Inst (2005) 4.45
Exposure to diesel motor exhaust and lung cancer risk in a pooled analysis from case-control studies in Europe and Canada. Am J Respir Crit Care Med (2010) 4.35
EMSY links the BRCA2 pathway to sporadic breast and ovarian cancer. Cell (2003) 4.33
Association between smoking and risk of bladder cancer among men and women. JAMA (2011) 4.31
Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium. Lancet Oncol (2006) 4.13
Improved identification of von Hippel-Lindau gene alterations in clear cell renal tumors. Clin Cancer Res (2008) 4.02
Alcohol and cause-specific mortality in Russia: a retrospective case-control study of 48,557 adult deaths. Lancet (2009) 4.01
The genetics and genomics of cancer. Nat Genet (2003) 3.97
Helicobacter pylori and esophageal cancer risk: a meta-analysis. Cancer Prev Res (Phila) (2008) 3.97
A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci. Nat Genet (2010) 3.93
Health Effects of Overweight and Obesity in 195 Countries over 25 Years. N Engl J Med (2017) 3.90
Oral use of Swedish moist snuff (snus) and risk for cancer of the mouth, lung, and pancreas in male construction workers: a retrospective cohort study. Lancet (2007) 3.84
Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium. Blood (2008) 3.81
Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution. Ann Surg (2007) 3.73
Detectable clonal mosaicism and its relationship to aging and cancer. Nat Genet (2012) 3.69
Investigation of the fine structure of European populations with applications to disease association studies. Eur J Hum Genet (2008) 3.65
Common variants in WFS1 confer risk of type 2 diabetes. Nat Genet (2007) 3.58
Listing occupational carcinogens. Environ Health Perspect (2004) 3.57
Alcohol poisoning is a main determinant of recent mortality trends in Russia: evidence from a detailed analysis of mortality statistics and autopsies. Int J Epidemiol (2008) 3.56
A shared susceptibility locus in PLCE1 at 10q23 for gastric adenocarcinoma and esophageal squamous cell carcinoma. Nat Genet (2010) 3.53
Dietary fibre in food and protection against colorectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC): an observational study. Lancet (2003) 3.53
Coffee intake is associated with lower rates of liver disease progression in chronic hepatitis C. Hepatology (2009) 3.50
Modified Mediterranean diet and survival: EPIC-elderly prospective cohort study. BMJ (2005) 3.48
Validity and repeatability of the EPIC-Norfolk Physical Activity Questionnaire. Int J Epidemiol (2002) 3.38
Exposure to oral bisphosphonates and risk of esophageal cancer. JAMA (2010) 3.37
Interaction between tobacco and alcohol use and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. Cancer Epidemiol Biomarkers Prev (2009) 3.33
A road map for efficient and reliable human genome epidemiology. Nat Genet (2006) 3.21
Replication of lung cancer susceptibility loci at chromosomes 15q25, 5p15, and 6p21: a pooled analysis from the International Lung Cancer Consortium. J Natl Cancer Inst (2010) 3.18
Carcinogenicity of radiofrequency electromagnetic fields. Lancet Oncol (2011) 3.18
Prevalence of metabolic syndrome in an urban population: Tehran Lipid and Glucose Study. Diabetes Res Clin Pract (2003) 3.06
Inflammatory and metabolic biomarkers and risk of liver and biliary tract cancer. Hepatology (2014) 3.06
Serum vitamin D concentration and prostate cancer risk: a nested case-control study. J Natl Cancer Inst (2008) 3.04
Opposing risks of gastric cardia and noncardia gastric adenocarcinomas associated with Helicobacter pylori seropositivity. J Natl Cancer Inst (2006) 2.97
A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma. Nature (2011) 2.96
Genome-wide association study of renal cell carcinoma identifies two susceptibility loci on 2p21 and 11q13.3. Nat Genet (2010) 2.96
Fruit, vegetables, and colorectal cancer risk: the European Prospective Investigation into Cancer and Nutrition. Am J Clin Nutr (2009) 2.93
Lung cancer occurrence in never-smokers: an analysis of 13 cohorts and 22 cancer registry studies. PLoS Med (2008) 2.90
Fruit and vegetable intake and the risk of stomach and oesophagus adenocarcinoma in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST). Int J Cancer (2006) 2.89
Mcl-1 expression has in vitro and in vivo significance in chronic lymphocytic leukemia and is associated with other poor prognostic markers. Blood (2008) 2.88
Evaluation of human papillomavirus antibodies and risk of subsequent head and neck cancer. J Clin Oncol (2013) 2.87
Tooth loss is associated with increased risk of total death and death from upper gastrointestinal cancer, heart disease, and stroke in a Chinese population-based cohort. Int J Epidemiol (2005) 2.87
Tumor necrosis factor (TNF) and lymphotoxin-alpha (LTA) polymorphisms and risk of non-Hodgkin lymphoma in the InterLymph Consortium. Am J Epidemiol (2010) 2.86
Environmental causes of esophageal cancer. Gastroenterol Clin North Am (2009) 2.80
Lung cancer in never smokers: clinical epidemiology and environmental risk factors. Clin Cancer Res (2009) 2.77
Renal cell carcinoma in relation to cigarette smoking: meta-analysis of 24 studies. Int J Cancer (2005) 2.73
Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium. Hum Mol Genet (2011) 2.72